Indexed keywords
INFLIXIMAB;
MERCAPTOPURINE;
METHOTREXATE;
STEROID;
ABDOMINAL CRAMP;
ABDOMINAL PAIN;
ADULT;
BURNING SENSATION;
CASE REPORT;
COLON CROHN DISEASE;
DIARRHEA;
DRUG INDUCED HEADACHE;
DRUG WITHDRAWAL;
FEMALE;
FLU LIKE SYNDROME;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LABORATORY TEST;
LETTER;
LIMB PAIN;
LOOSE FECES;
LOW BACK PAIN;
NAUSEA;
NERVE CONDUCTION;
PANCREATITIS;
PARESTHESIA;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
PROTEIN ELECTROPHORESIS;
RASH;
SENSORIMOTOR NEUROPATHY;
VOMITING;
6-MERCAPTOPURINE;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
EXANTHEMA;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
PERIPHERAL NERVOUS SYSTEM DISEASES;
STEROIDS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
1
34249744516
Serious Adverse Events with Infliximab: Analysis of Spontaneously Reported Adverse Events
DOI 10.1016/j.cgh.2007.02.016, PII S1542356507001875
Hansen RA, Gartlehner G, Powell GE, et al. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol. 2007;5:729-735. (Pubitemid 46830051)
(2007)
Clinical Gastroenterology and Hepatology
, vol.5
, Issue.6
Hansen, R.A.1
Gartlehner, G.2
Powell, G.E.3
Sandler, R.S.4
2
39749167232
Tumor necrosis factor-α antagonists and neuropathy
DOI 10.1002/mus.20924
Stubgen JP. Tumor necrosis factor-α antagonists and neuropathy. Muscle Nerve. 2008;37:281-292. (Pubitemid 351304787)
(2008)
Muscle and Nerve
, vol.37
, Issue.3
, pp. 281-292
Stubgen, J.-P.1
3
0033546665
TNF neutralization in MS: Results of a randomised, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group
The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomised, placebo-controlled multicenter study. Neurology. 1999;53:457-465.
(1999)
Neurology
, vol.53
, pp. 457-465
4
0029751983
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
Van Oosten BW, Barkhof F, Truyen L, et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 1996;47:1531-1534. (Pubitemid 26422549)
(1996)
Neurology
, vol.47
, Issue.6
, pp. 1531-1534
Van Oosten, B.W.1
Barkhof, F.2
Truyen, L.3
Boringa, J.B.4
Bertelsmann, F.W.5
Von Blomberg, B.M.E.6
Woody, J.N.7
Hartung, H.-P.8
Polman, C.H.9
5
17644407732
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-α blockers
Richez C, Blanco P, Lagueny A, et al. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-α blockers. Neurology. 2005;64:1468-1470. (Pubitemid 40570527)
(2005)
Neurology
, vol.64
, Issue.8
, pp. 1468-1470
Richez, C.1
Blanco, P.2
Lagueny, A.3
Schaeverbeke, T.4
Dehais, J.5
6
33845874892
Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment
DOI 10.1007/s10067-006-0317-z
Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol. 2007;26:258-260. (Pubitemid 46020257)
(2007)
Clinical Rheumatology
, vol.26
, Issue.2
, pp. 258-260
Tektonidou, M.G.1
Serelis, J.2
Skopouli, F.N.3
7
5044226801
Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis
Richette P, Dieude P, Damiano J, et al. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol. 2004;31:2079-2081. (Pubitemid 39336740)
(2004)
Journal of Rheumatology
, vol.31
, Issue.10
, pp. 2079-2081
Richette, P.1
Dieude, P.2
Damiano, J.3
Lacroix, C.4
Liote, F.5
Orcel, P.6
Bardin, T.7